Ligand validation:1TZL

FAD: FLAVIN-ADENINE DINUCLEOTIDE

FAD is a Ligand Of Interest in 1TZL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1TZL_FAD_F_625	98%	32%	0.057	0.976	1.17	1.54	4	13	0	0	100%	1
1TZL_FAD_H_625	98%	33%	0.054	0.972	1.27	1.36	8	10	0	0	100%	1
1TZL_FAD_E_625	96%	22%	0.058	0.968	1.59	1.63	6	13	2	0	100%	1
1TZL_FAD_A_625	96%	28%	0.058	0.967	1.24	1.63	6	13	0	0	100%	1
1TZL_FAD_C_625	96%	27%	0.058	0.967	1.49	1.45	7	11	0	0	100%	1
1TZL_FAD_G_625	94%	26%	0.064	0.963	1.51	1.49	6	11	0	0	100%	1
1TZL_FAD_D_625	88%	30%	0.072	0.948	1.28	1.5	5	14	1	0	100%	1
1TZL_FAD_B_625	88%	14%	0.073	0.947	2.32	1.53	8	15	7	0	100%	1
2IGK_FAD_B_801	100%	24%	0.038	0.987	1.43	1.65	8	12	8	0	100%	1
3FDY_FAD_A_801	100%	20%	0.046	0.988	1.35	2.01	5	20	0	0	100%	1
2IGM_FAD_B_801	99%	10%	0.055	0.985	1.37	2.92	7	20	13	0	100%	1
3K4L_FAD_A_801	98%	21%	0.059	0.984	1.41	1.87	9	19	5	0	100%	1
3PL8_FAD_A_801	98%	36%	0.065	0.99	1.35	1.17	8	4	1	0	100%	1
1LQU_FAD_A_1457	100%	43%	0.023	0.995	1.03	1.18	2	5	0	0	100%	1
2R4J_FAD_B_600	100%	13%	0.024	0.995	2	1.99	18	19	0	0	100%	1
3IC9_FAD_B_490	100%	32%	0.025	0.996	1.23	1.45	7	8	0	0	100%	1
4OMF_FAD_B_405	100%	14%	0.015	0.998	2.27	1.57	9	13	0	0	100%	1
4XWR_FAD_A_601	100%	53%	0.018	0.997	0.97	0.86	4	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.